Intermittent Preventive Treatment in Pregnancy With Sulphadoxine-Pyrimethamine Plus Dihydroartemisinin-Piperaquine to Reduce Adverse Pregnancy Outcomes and Prevent Malaria in Papua New Guinea: A Randomised Controlled Trial

Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?

HW Unger, R Ataide, ME Roh, A Rahman, RN Price, AM van Eijk, G Dorsey, FO Ter Kuile, SJ Rogerson

2026-01-01

Efforts to reduce the global burden of small vulnerable newborns (SVNs) by scaling up existing preventive interventions must be co..

Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study

E Lufele, S Pascoe, A Mengi, A Auwun, N Neuendorf, JW Bolnga, M Laman, SJ Rogerson, K Thriemer, HW Unger

2025-12-01

Background: In moderate-to-high malaria transmission regions, the World Health Organization recommends intermittent preventive tre..

Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study

P Cellich, HW Unger, SJ Rogerson, GDL Mola

2024-12-01

Background: Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) reduces malaria-attributable a..

Adapting international clinical trials during COVID-19 and beyond

K Thriemer, TS Degaga, MS Alam, B Adhikari, R Tripura, MS Hossain, M Christian, NK Ghanchi, H Mnjala, S Weston, B Ley, A Rumaseb, D Tadesse, T Teferi, D Yilma, G Lee, H Unger, I Sutanto, AP Pasaribu, P Ghimire

2023-06-01

Background: The COVID-19 pandemic and resulting restrictions, particularly travel restrictions, have had significant impact on the..